生物催化丙烯酰胺（BioACM）市场－全球产业规模、份额、趋势、机会、预测：按应用、地区和竞争格局划分，2021-2031年

全球生物催化丙烯酰胺 (BioACM) 市场预计将从 2025 年的 40.5 亿美元成长到 2031 年的 65.1 亿美元，复合年增长率为 8.23%。

生物基丙烯酰胺（BioACM）是一种高纯度化学单体，它是利用生物催化剂，透过丙烯腈的酶促水合反应而得的，可取代传统的铜基製程。该市场的主要驱动力是污水处理和强化石油开采领域对聚丙烯酰胺日益增长的需求，在这些领域，高分子量聚合物对于高效能絮凝和黏度控制至关重要。此外，绿色化学理念的推广也推动了该产业的发展，因为生物催化製程能够显着降低能耗，并消除传统合成方法产生的有害废弃物。根据欧洲生质塑胶协会预测，到2024年，全球生质塑胶产能将达到247万吨，这显示产业正加速向利用此类生物基单体的永续聚合物生态系统转型。

阻碍生物基丙烯酰胺（BioACM）市场快速成长的主要障碍是来自现有化学丙烯酰胺生产设施的激烈经济竞争。许多现有生产商经营已完全折旧免税额的铜催化剂装置，从而维持了较低的边际生产成本，使得新的生物催化设施在没有监管激励的情况下难以在价格上与之竞争。此外，该市场仍然高度依赖主要原材料丙烯腈的价格波动，这可能导致利润率不可预测地下降，并阻碍对扩大生物基生产能力的资本投资。

市场驱动因素

全球对聚丙烯酰胺在水和污水处理领域日益增长的需求是生物催化丙烯酰胺市场的主要驱动力。市政机构和工业业者越来越多地在高效污泥脱水和水净化製程中使用高分子量聚合物。与铜基催化剂相比，生物催化生产过程能够显着减少丙烯酰胺的杂质含量，从而实现超高分子量凝聚剂的聚合，而这些絮凝剂对于现代过滤基础设施至关重要。随着优化现有设施的重要性超过新建设，对这种先进化学处理的依赖性也不断增强。事实上，根据Black & Bitch发布的《2024年水资源报告》，65%的受访供水事业经理认为基础设施老化是他们面临的最大挑战，凸显了开发高效化学解决方案以延长处理设施运作的必要性。

全球向环境永续的绿色化学转型，进一步加速了生物基製造流程的普及。与需要高温且会产生重金属废弃物的传统水解方法不同，生物催化剂可在常压和常温条件下运行，从而显着提高製程安全性并减少碳足迹。这种与企业永续性目标的契合，正促使化学製造商逐步淘汰高能耗的铜催化剂。根据美国农业部2024年3月发布的报告《美国生物基产品产业影响分析》，生物基产品产业为美国经济贡献了4,890亿美元的价值，反映了生物合成技术背后强劲的经济动力。这一永续性趋势也为SNF集团等大型聚丙烯酰胺生产商提供了支持。 SNF集团报告称，其2024年聚丙烯酰胺活性当量总产能将达到145万吨，凸显了依赖可靠丙烯酰胺原料的下游市场的巨大规模。

市场挑战

现有化学丙烯酰胺生产设施带来的激烈经济竞争是生物基丙烯酰胺（BioACM）市场成长的主要障碍。现有生产商主要利用折旧免税额的铜催化剂装置，使其营运成本远低于新建生物催化剂装置所需的高资本投资。这种成本差异使得新参与企业生物基市场的企业难以获得具有竞争力的价格，尤其是在污水处理等价格敏感型产业，这些产业往往优先考虑采购量而非永续性指标。因此，无法跟上现有生产商激进的定价策略会削弱新进入市场企业的潜在利润率。

传统化学品製造地的持续扩张加剧了这项挑战，进一步巩固了传统合成方法的市场主导地位。根据美国化学工业协会（ACC）预测，2024年底，作为全球领先的传统丙烯酰胺合成中心，中国的化学品产量将年增9.7%。成熟化学品行业的如此强劲增长表明，现有生产商能够维持其规模和产能，从而比新兴的生物基竞争对手更有效地应对原材料价格的波动，进而阻碍了对替代生产路线的资本投资。

市场趋势

可再生生物基丙烯腈原料的引进，正从根本上重塑全球生物催化丙烯酰胺（BioACM）市场，使其能够生产完全永续的单体。虽然生物催化水合製程本身就对环境友好，但该产业目前正朝着整个价值链的脱碳方向发展，以生物质衍生的前体取代化石基丙烯。这项转变使製造商能够提供碳足迹显着降低的产品，满足下游聚合物消费者严格的范围3排放目标。例如，英力士腈类公司于2024年4月推出了一条新产品线，与同等化石基产品相比，该产品线可减少90%的温室气体排放，为原料永续性树立了新的标竿。

与此同时，新兴亚洲经济区的製造业产能正经历决定性的扩张。这主要是由于供应链需要本地化，以贴近高成长的应用领域。生产商正大力投资这些地区的新设施，以直接满足强化石油开采和水处理行业日益增长的需求，从而降低长途运输带来的物流成本和供应风险。这种策略性在地化正在建立一个体系，使大型基础设施计划能够即时获得必要的化学原料。例如，SNF集团于2024年1月宣布了一项在阿曼投资2.5亿美元的开发计划，旨在扩大强化石油开采解决方案的产能。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球生物催化丙烯酰胺（BioACM）市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依应用领域（水处理、石油天然气、造纸等）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美生物催化丙烯酰胺（BioACM）市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲生物催化丙烯酰胺（BioACM）市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区生物催化丙烯酰胺（BioACM）市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲生物催化丙烯酰胺（BioACM）市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲生物催化丙烯酰胺（BioACM）市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球生物催化丙烯酰胺（BioACM）市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• BASF SE
• Kemira Oyj
• SNF Group
• Mitsubishi Chemical Corporation
• Nitto Denko Corporation
• Arkema Group
• Ashland Global Holdings Inc.
• Solvay SA
• Nippon Shokubai Co., Ltd.
• Sumitomo Chemical Co., Ltd.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Biocatalyzed Acrylamide (BioACM) Market is projected to expand from USD 4.05 Billion in 2025 to USD 6.51 Billion by 2031, reflecting a CAGR of 8.23%. BioACM is a high-purity chemical monomer created through the enzymatic hydration of acrylonitrile using a biological catalyst instead of the traditional copper-based process. The market is chiefly supported by the rising demand for polyacrylamide in wastewater treatment and enhanced oil recovery, where high-molecular-weight polymers are critical for efficient flocculation and viscosity modification. Furthermore, the industry is driven by the necessity to adopt green chemistry principles, as the biocatalytic route significantly lowers energy consumption and removes the hazardous waste associated with conventional synthesis. According to European Bioplastics, global bioplastics production capacity reached 2.47 million tonnes in 2024, highlighting the accelerating industrial shift toward sustainable polymer ecosystems utilizing such biobased monomers.

A major obstacle impeding the rapid growth of the BioACM market is intense economic competition from established chemical acrylamide production facilities. Many incumbent manufacturers operate fully depreciated copper catalysis plants that maintain low marginal production costs, making it challenging for new biocatalytic facilities to compete on price without regulatory incentives. Additionally, the market remains heavily dependent on the price volatility of acrylonitrile, the primary feedstock, which can unpredictably diminish profit margins and discourage capital investment in new biobased capacity expansions.

Market Driver

The escalating global demand for polyacrylamide in water and wastewater treatment serves as a primary catalyst for the biocatalyzed acrylamide market. Municipalities and industrial operators rely extensively on high-molecular-weight polymers for effective sludge dewatering and water clarification processes. The biocatalytic production route yields acrylamide with significantly fewer impurities than copper-based catalysis, allowing for the polymerization of ultra-high molecular weight flocculants essential for modern filtration infrastructure. This reliance on advanced chemical treatment is growing as utilities face increasing pressure to optimize existing assets rather than construct new ones; indeed, Black & Veatch's '2024 Water Report' noted that 65 percent of surveyed water utility leaders identified aging infrastructure as their most significant challenge, underscoring the critical need for efficient chemical solutions to extend the operational lifespan of treatment facilities.

A global shift toward environmentally sustainable green chemistry practices further hastens the adoption of bio-based manufacturing processes. Unlike traditional hydration methods that require high temperatures and generate heavy metal waste, biocatalysis operates under ambient pressure and temperature conditions, offering substantial improvements in process safety and carbon footprint reduction. This alignment with corporate sustainability goals is driving chemical manufacturers to transition away from energy-intensive copper catalysts. According to the U.S. Department of Agriculture's March 2024 report, 'An Economic Impact Analysis of the U.S. Biobased Products Industry', the biobased products sector contributed USD 489 billion in value added to the U.S. economy, reflecting strong economic momentum behind biological synthesis methods. This sustainability trend supports major polyacrylamide producers like SNF Group, which reported a total production capacity of 1.45 million tonnes of polyacrylamide active equivalent in 2024, highlighting the vast scale of the downstream market dependent on reliable acrylamide feedstocks.

Market Challenge

Intense economic competition from established chemical acrylamide production facilities serves as a substantial barrier to the growth of the BioACM market. Incumbent manufacturers predominantly utilize fully depreciated copper catalysis plants, allowing them to operate with significantly lower marginal costs compared to the high capital expenditure required for constructing new biocatalytic facilities. This cost disparity makes it difficult for biobased entrants to achieve competitive pricing, particularly in price-sensitive sectors like wastewater treatment where procurement is driven by volume rather than sustainability metrics. Consequently, the inability to match the aggressive pricing strategies of legacy producers often erodes potential profit margins for new market players.

This challenge is exacerbated by the continued expansion of traditional chemical manufacturing hubs, which reinforces the market dominance of conventional synthesis methods. According to the American Chemistry Council, in late 2024, chemical production in China-a primary global hub for traditional acrylamide synthesis-recorded a year-on-year output increase of 9.7%. Such robust growth in the established chemical sector suggests that legacy producers retain the scale and capacity to absorb feedstock price volatility more effectively than emerging biobased competitors, thereby deterring capital investment in alternative production routes.

Market Trends

The integration of renewable bio-based acrylonitrile feedstocks is fundamentally reshaping the Global Biocatalyzed Acrylamide (BioACM) Market by enabling the production of fully sustainable monomers. While the biocatalytic hydration process itself is green, the industry is now moving to decarbonize the entire value chain by replacing fossil-derived propylene with biomass-sourced precursors. This shift allows manufacturers to offer products with a significantly reduced carbon footprint, catering to the stringent scope 3 emission targets of downstream polymer consumers. For instance, INEOS Nitriles launched a new product line in April 2024 that delivers a 90% reduction in greenhouse gas emissions compared to fossil-based equivalents, setting a new benchmark for raw material sustainability.

Simultaneously, the market is witnessing a decisive expansion of manufacturing capacities in emerging Asian economies, driven by the need to localize supply chains near high-growth application sectors. Producers are investing heavily in new facilities within these regions to serve the escalating requirements of the enhanced oil recovery and water treatment industries directly, thereby mitigating logistics costs and supply risks associated with long-haul transportation. This strategic localization ensures that large-scale infrastructure projects have immediate access to essential chemical inputs, as evidenced by SNF Group's announcement in January 2024 of a USD 250 million development plan to expand its production capabilities in Oman for enhanced oil recovery solutions.

Key Market Players

• BASF SE
• Kemira Oyj
• SNF Group
• Mitsubishi Chemical Corporation
• Nitto Denko Corporation
• Arkema Group
• Ashland Global Holdings Inc.
• Solvay S.A.
• Nippon Shokubai Co., Ltd.
• Sumitomo Chemical Co., Ltd.

Report Scope

In this report, the Global Biocatalyzed Acrylamide (BioACM) Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biocatalyzed Acrylamide (BioACM) Market, By Application

• Water Treatment
• Oil & Gas
• Paper Making
• Others

Biocatalyzed Acrylamide (BioACM) Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biocatalyzed Acrylamide (BioACM) Market.

Available Customizations:

Global Biocatalyzed Acrylamide (BioACM) Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biocatalyzed Acrylamide (BioACM) Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Water Treatment, Oil & Gas, Paper Making and Others)
  • 5.2.2. By Region
  • 5.2.3. By Company (2025)
• 5.3. Market Map

6. North America Biocatalyzed Acrylamide (BioACM) Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
  • 6.3.2. Canada Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
  • 6.3.3. Mexico Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application

7. Europe Biocatalyzed Acrylamide (BioACM) Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
  • 7.3.2. France Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
  • 7.3.3. United Kingdom Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
  • 7.3.4. Italy Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
  • 7.3.5. Spain Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application

8. Asia Pacific Biocatalyzed Acrylamide (BioACM) Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
  • 8.3.2. India Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
  • 8.3.3. Japan Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
  • 8.3.4. South Korea Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
  • 8.3.5. Australia Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application

9. Middle East & Africa Biocatalyzed Acrylamide (BioACM) Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
  • 9.3.2. UAE Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
  • 9.3.3. South Africa Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application

10. South America Biocatalyzed Acrylamide (BioACM) Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
  • 10.3.2. Colombia Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
  • 10.3.3. Argentina Biocatalyzed Acrylamide (BioACM) Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Biocatalyzed Acrylamide (BioACM) Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. BASF SE
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Kemira Oyj
• 15.3. SNF Group
• 15.4. Mitsubishi Chemical Corporation
• 15.5. Nitto Denko Corporation
• 15.6. Arkema Group
• 15.7. Ashland Global Holdings Inc.
• 15.8. Solvay S.A.
• 15.9. Nippon Shokubai Co., Ltd.
• 15.10. Sumitomo Chemical Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer